Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 27, 2022

BUY
$58.92 - $84.67 $29,460 - $42,335
500 Added 2.44%
21,010 $1.3 Million
Q2 2022

Jul 19, 2022

BUY
$79.4 - $116.36 $71,539 - $104,840
901 Added 4.59%
20,510 $1.64 Million
Q1 2022

Apr 27, 2022

BUY
$86.42 - $109.81 $31,888 - $40,519
369 Added 1.92%
19,609 $2.06 Million
Q4 2021

Jan 24, 2022

SELL
$98.56 - $119.91 $900,641 - $1.1 Million
-9,138 Reduced 32.2%
19,240 $2.07 Million
Q3 2021

Oct 15, 2021

BUY
$91.91 - $110.37 $137,313 - $164,892
1,494 Added 5.56%
28,378 $3.11 Million
Q2 2021

Jul 16, 2021

BUY
$86.24 - $95.92 $119,442 - $132,849
1,385 Added 5.43%
26,884 $2.52 Million
Q1 2021

Apr 19, 2021

BUY
$71.83 - $95.48 $87,632 - $116,485
1,220 Added 5.02%
25,499 $2.35 Million
Q4 2020

Feb 01, 2021

BUY
$67.0 - $84.39 $122,878 - $154,771
1,834 Added 8.17%
24,279 $1.78 Million
Q3 2020

Oct 20, 2020

SELL
$55.23 - $79.93 $497,401 - $719,849
-9,006 Reduced 28.64%
22,445 $1.74 Million
Q2 2020

Jul 27, 2020

BUY
$30.2 - $56.98 $9,392 - $17,720
311 Added 1.0%
31,451 $1.75 Million
Q1 2020

Apr 27, 2020

SELL
$24.87 - $38.56 $43,248 - $67,055
-1,739 Reduced 5.29%
31,140 $922,000
Q4 2019

Jan 22, 2020

BUY
$25.43 - $36.67 $5,696 - $8,214
224 Added 0.69%
32,879 $1.19 Million
Q3 2019

Oct 23, 2019

SELL
$23.0 - $27.97 $5,681 - $6,908
-247 Reduced 0.75%
32,655 $889,000
Q2 2019

Jul 24, 2019

BUY
$22.81 - $28.48 $750,494 - $937,048
32,902 New
32,902 $792,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Campbell Newman Asset Management Inc Portfolio

Follow Campbell Newman Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell Newman Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Campbell Newman Asset Management Inc with notifications on news.